NASDAQ · Financial Statements
Spruce Biosciences, Inc. (SPRB) Financial Statements
$39.65
NASDAQ: SPRB
Market Cap $113.95M
Overview Financials Dividend
Spruce Biosciences, Inc. most recently reported annual revenue of $0, a net loss of $39.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $10.0M $5.0M $0 Operating Profit $-42.0M $-47.0M $-52.0M $-56.0M $-37.0M Net Profit $-42.0M $-46.0M $-48.0M $-53.0M $-39.0M EPS $-68.25 $-72.00 $-93.00 $-96.75 $-50.83 Op Margin — — -515.3% -1143.4% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $126.0M $86.0M $104.0M $45.0M $53.0M Total Liabilities $15.0M $17.0M $27.0M $16.0M $11.0M Cash $43.0M $24.0M $96.0M $39.0M $49.0M Borrowings $7.0M $6.0M $5.0M $3.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-36.0M $-42.0M $-33.0M $-56.0M $-33.0M Investing Cash Flow $-79.0M $24.0M $56.0M $0 $0 Financing Cash Flow $0 $0 $-3.0M $0 $-5.0M Net Cash Flow $-114.0M $-18.0M $72.0M $-58.0M $10.0M Free Cash Flow $-36.0M $-42.0M $-33.0M $-56.0M $-33.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -0.76 FCF Yield -34.00% Quick Ratio 9.23 Interest Coverage -26.63 Return 1Y -91.62% Return 3Y -99.61% Return 5Y -99.92%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .